On June 10, Sun Hung Kai Co (00086) spent HK$489,400 to repurchase 119,000 shares.
New World Development Company Limited (00086) announced that on June 10, 2026, it spent 48.94 million Hong Kong dollars to repurchase 119,000 shares; canceling 302,000 shares of repurchased shares.
SUN HUNG KAI CO (00086) announces that on June 10, 2026, it spent HK$489,400 to repurchase 11,900 shares; 302,000 repurchased shares have been cancelled.
Related Articles
SIPAI HEALTH (00314) repurchased 200,000 shares at a cost of approximately HKD 240,200 on June 10th.
ALPHAMAB-B(09966): The phase III clinical study of Anituximab (KN026) as first-line treatment for HER2-positive advanced breast cancer has reached the primary endpoint.
CSPC PHARMA (01093): The phase III study of the combination of Anetumab ravtansine (KN026) with albumin-bound paclitaxel (HB1801) for first-line treatment for HER2-positive advanced breast cancer has reached its primary endpoint.
SIPAI HEALTH (00314) repurchased 200,000 shares at a cost of approximately HKD 240,200 on June 10th.
ALPHAMAB-B(09966): The phase III clinical study of Anituximab (KN026) as first-line treatment for HER2-positive advanced breast cancer has reached the primary endpoint.
CSPC PHARMA (01093): The phase III study of the combination of Anetumab ravtansine (KN026) with albumin-bound paclitaxel (HB1801) for first-line treatment for HER2-positive advanced breast cancer has reached its primary endpoint.
RECOMMEND
